CYAMEMAZINE VIATRIS 100 mg, film-coated tablet scored 25 tablets
Active ingredients: Cyamemazine, Cyamemazine tartrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored25 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CYAMEMAZINE VIATRIS 100 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 25 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Feb 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60125777CIP73016419CIP133400930164198Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TARTRATE DE CYAMÉMAZINEcomprimé | 146,400 mg · un comprimé | SA |
| CYAMÉMAZINEcomprimé | 100 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.